Alessandro Squizzato Selected Research

Alessandro Squizzato Research Topics

Disease

24	Hemorrhage 01/2022 - 12/2005
18	Pulmonary Embolism 01/2022 - 11/2005
16	Thrombosis (Thrombus) 09/2021 - 12/2005
14	Venous Thromboembolism 01/2021 - 05/2004
12	Venous Thrombosis (Deep-Vein Thrombosis) 09/2021 - 01/2003
12	Neoplasms (Cancer) 03/2021 - 05/2004
11	Ischemic Stroke 01/2022 - 11/2005
11	Atrial Fibrillation 01/2021 - 12/2009
10	Stroke (Strokes) 01/2022 - 07/2013
4	Thrombocytopenia (Thrombopenia) 01/2022 - 12/2010
4	Infections 01/2020 - 08/2011
4	Disseminated Intravascular Coagulation 01/2020 - 05/2012
4	Acute Coronary Syndrome 09/2018 - 12/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2009
3	Transient Ischemic Attack 01/2022 - 08/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021 - 09/2008
3	Peripheral Arterial Disease 01/2018 - 01/2011
3	Liver Diseases (Liver Disease) 12/2014 - 05/2007
3	Hypothyroidism 05/2014 - 04/2012
2	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2021
2	Disease Susceptibility (Diathesis) 09/2021 - 05/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2021 - 08/2019
2	Sepsis (Septicemia) 01/2020 - 05/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2018
2	Vascular Diseases (Vascular Disease) 01/2020 - 12/2019
2	Inflammation (Inflammations) 12/2019 - 08/2011
2	Rhabdomyolysis 01/2019 - 08/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 04/2015
2	Myocardial Infarction 01/2018 - 12/2017
2	Chronic Hepatitis C 01/2018 - 12/2014
2	Coronary Disease (Coronary Heart Disease) 12/2017 - 01/2011
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2017 - 01/2011
2	Embolism (Embolus) 10/2015 - 12/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 07/2009
2	Hyperthyroidism 12/2012 - 12/2007
2	Thromboembolism 09/2011 - 12/2005
2	Obesity 08/2009 - 10/2006
2	Thrombophilia 08/2009 - 10/2006
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Psoriatic Arthritis 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Factor XII Deficiency 09/2021
1	Fever (Fevers) 06/2021
1	Cardiotoxicity 03/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Ascites 12/2020
1	Hepatitis C 11/2020

Drug/Important Bio-Agent (IBA)

22	AnticoagulantsIBA 01/2021 - 12/2005
10	Vitamin K FDA Link 01/2021 - 05/2004
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2008
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2011
6	fibrin fragment D (D-dimer)IBA 09/2021 - 11/2005
5	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 05/2004
5	Pharmaceutical PreparationsIBA 11/2020 - 12/2009
4	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2011
4	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 05/2012
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2019 - 01/2011
3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 12/2010
3	von Willebrand FactorIBA 09/2021 - 08/2009
3	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2014 - 06/2010
3	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 01/2003
2	Hormones (Hormone)IBA 12/2021 - 02/2011
2	AntibodiesIBA 09/2021 - 12/2007
2	Antiviral Agents (Antivirals)IBA 11/2020 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 09/2018
2	oxidized low density lipoproteinIBA 01/2018 - 10/2017
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 06/2017 - 01/2015
2	LipidsIBA 01/2016 - 05/2010
2	Factor VIIa (Activated Factor VII)IBA 08/2015 - 05/2007
2	Fibric Acids (Fibrates)IBA 12/2012 - 05/2010
2	Hemostatics (Antihemorrhagics)IBA 07/2012 - 08/2009
1	TicagrelorIBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2021
1	Janus Kinase InhibitorsIBA 10/2021
1	AnthracyclinesIBA 03/2021
1	edoxabanIBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 12/2020
1	SaltsIBA 12/2020
1	DiureticsIBA 12/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2020
1	Cytochrome P-450 CYP3AIBA 11/2020
1	CreatinineIBA 01/2020

Therapy/Procedure

21	Therapeutics 01/2022 - 05/2004
5	Secondary Prevention 01/2022 - 07/2008
4	Stents 01/2020 - 04/2015
3	Thrombolytic Therapy 01/2022 - 04/2015
3	Drug Therapy (Chemotherapy) 03/2021 - 01/2012
3	Percutaneous Coronary Intervention 01/2020 - 10/2011
3	Length of Stay 12/2019 - 08/2017
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2016 - 08/2015
2	Catheters 01/2016 - 06/2009
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2015 - 10/2011
1	Duration of Therapy 01/2022
1	Preoperative Period 09/2021
1	Thermometers 06/2021
1	Transjugular Intrahepatic Portasystemic Shunt 12/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2020
1	Liver Transplantation 12/2020